http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-94007471-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e34ed063232fca5ab7e940a34d0b8989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_018460f261c6c370b0846603d31ecef3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00
filingDate 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59065c997f22b9b5b2cfe3155fb22b9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62e882f20b860cc5752bc26132869ac
publicationDate 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-94007471-A
titleOfInvention Method of mastopathy treatment
abstract The invention relates to medicine and can be used in the treatment of diffuse estrogen-dependent mastopathy. The main objective of the invention is to eliminate the side effects of the drug and reduce the treatment of mastopathy. The problem is solved in that in the method of treating mastopathy, including the introduction of tamoxifen, tamoxifen in an amount of 0.5-3.0 wt.% Is introduced into the ointment base, which is close to the skin fat in water-fat balance, applied directly to the mammary gland and exposed the action of a magnetic field for 10-20 minutes, and the procedure is repeated 4-8 times with an interval of a day. The proposed method for the treatment of mastopathy contributes to the rapid stabilization of the process (5-7 days against 84), eliminates surgical intervention and the side effect of the drug on the body.
priorityDate 1994-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526

Total number of triples: 14.